oxazoles has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunosewoyo, H; Jiang, QH; Pang, T; Shi, JJ; Shi, WW; Sun, H; Tang, J; Yang, F; Yu, LF; Zhang, TN | 1 |
| Bassetti, CL; Doeppner, TR; Dzyubenko, E; Hermann, DM; Kaltwasser, B; Kleinschnitz, C; Machado, P; Sanchez-Mendoza, EH; Sardari, M; Silva de Carvalho, T; Wang, YC | 1 |
2 other study(ies) available for oxazoles and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Infarction, Middle Cerebral Artery; Male; Molecular Structure; Motor Activity; Neuronal Outgrowth; Oxazoles; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, sigma; Recovery of Function; Sigma-1 Receptor | 2021 |
Postacute Delivery of GABA
Topics: Animals; Benzodiazepines; Brain; GABA Antagonists; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neuronal Plasticity; Neurons; Neuroprotection; Oxazoles; Receptors, GABA-A; Recovery of Function; Stroke | 2018 |